Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 11, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tiago Fauth Maintained (VTYX) at Buy with Decreased Target to $62 on, Aug 11th, 2023
Tiago Fauth of Credit Suisse, Maintained "Ventyx Biosciences, Inc." (VTYX) at Buy with Decreased Target from $63 to $62 on, Aug 11th, 2023.
Tiago has made no other calls on VTYX in the last 4 months.
There is 1 other peer that has a rating on VTYX. Out of the 1 peers that are also analyzing VTYX, 0 agree with Tiago's Rating of Hold.
This is the rating of the analyst that currently disagrees with Tiago
- Jeff Jones of "Oppenheimer" Reiterated at Buy and Held Target at $62 on, Wednesday, July 5th, 2023
